In vitro release testing method development for ophthalmic ointments

Abstract

It is essential as well as challenging to develop a reliable in vitro release testing method for determining whether differences in release profiles exist between qualitatively and quantitatively equivalent ophthalmic ointment formulations. There is a lack of regulatory guidance on in vitro release testing methods for ophthalmic formulations. Three different in vitro release testing methods 1) USP apparatus 4 with semisolid adapters; 2) USP apparatus 2 with enhancer cells; and 3) Franz diffusion cells were investigated. Qualitatively and quantitatively equivalent ointments were prepared via hot melting and simple mixing methods using four different sources of excipients (i.e. white petrolatum). The ointment formulations were characterized for content uniformity, particle size, and rheological parameters. All the formulations showed adequate content uniformity and similar particle size. The ointments prepared via the hot melting processes showed higher rheological parameters, as did the ointments prepared using 'white' petrolatum that exhibited a yellowish color. The three in vitro release testing methods were compared and evaluated for reproducibility, discriminatory capability, and correlation with the rheological parameters. Compared with the compendial methods, the non-compendial method (Franz diffusion cells) showed poorer reproducibility. All three methods possessed the ability to discriminate between the ophthalmic ointments with manufacturing differences. However, the USP apparatus 4 method displayed the largest margin of discrimination between the release profiles of the different ophthalmic ointments. In addition, the in vitro release rate obtained using the USP apparatus 4 method showed the strongest logarithmic linear correlation with the rheological parameters (Power law consistency index (K value) and crossover modulus) compared to the other two methods.

In Vitro Release Testing of Acyclovir Topical Formulations Using Immersion Cells

“…Several studies comparing the IVRT of various topical and ophthalmic semisolid formulations using immersion cells and VDCs have reported lower precision, reproducibility and higher variation in IVRT using VDCs.. [31][32][33][34][35][36] The main reasons for this are higher human interface during sample application and sample withdrawal, leading to higher experimental errors. 37 A number of studies have been reported in the literature where VDCs have been employed for testing the drug release and/or permeation from acyclovir topical formulations.…”

In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics

“…Various in vitro release studies of ophthalmic semisolid dosage forms were carried out using different apparatus [17]. Classic in vitro release studies focus only on the diffusion of the drug out of its dosage forms, often with an intervening membrane (e.g., dialysis methods, Franz diffusion cells).…”

Innovation for Generic Drugs: Science and Research Under the Generic Drug User Fee Amendments of 2012

“…For ophthalmic products, the FDA's ophthalmic research program integrates different aspects of Q3 evaluation on new methodologies for characterization of physicochemical properties of ophthalmic drug products, development, and evaluation of in vitro release testing methods and their capacity to predict in vivo performance and development of predictive modeling of ocular drug absorption …”